|
Complete Response in the overall phase
|
|
Gender:Male vs Female
|
0.005
|
1.830[1.204–2.783]
| | |
| Age: ≧65 vs < 65 |
0.090
|
1.438[0.945–2.187]
|
0.099
|
1.448[0.933–2.249]
|
|
Motion sickness: Yes vs No
|
0.003
|
0.422[0.241–0.740]
|
0.011
|
0.469[0.261–0.840]
|
|
Drinking habit: Yes vs No
|
0.032
|
1.578[1.040–2.394]
|
0.143
|
1.394[0.894–2.175]
|
|
Smoking History:Yes vs No
|
0.057
|
1.523[0.987–2.350]
| | |
|
Pregnancy associated vomiting: Yes vs Others
|
0.006
|
0.516[0.322–0.872]
|
0.040
|
0.589[0.355–0.977]
|
|
palonosetron vs 1st generation 5HT3RA
|
0.723
|
0.927[0.608–1.412]
|
0.070
|
0.560[0.300–1.048]
|
|
CBDCA-based chemotherapy vs Others
|
0.469
|
0.858[0.567–1.299]
|
0.027
|
0.494[0.264–0.922]
|
|
Total Control in overall phase
|
|
Gender:Male vs Female
|
0.002
|
1.911[1.275–2.864]
| | |
| Age: ≧65 vs < 65 |
0.004
|
1.807[1.205–2.709]
|
0.006
|
1.829[1.191–2.808]
|
|
Motion sickness: Yes vs No
|
0.003
|
0.408[0.226–0.734]
|
0.031
|
0.510[0.277–0.939]
|
|
Drinking habit: Yes vs No
|
0.006
|
1.755[1.172–2.628]
|
0.059
|
1.520[0.984–2.348]
|
|
Smoking History:Yes vs No
|
0.194
|
1.313[0.871–1.979]
| | |
|
Pregnancy associated vomiting: Yes vs Others
|
< 0.001
|
0.375[0.230–0.611]
|
0.003
|
0.460[0.275–0.770]
|
|
palonosetron vs 1st generation 5HT3RA
|
0.445
|
1.172[0.780–1.759]
| | |
|
CBDCA-based chemotherapy vs Others
|
0.364
|
0.831[0.557–1.239]
|
0.063
|
0.666[0.434–1.023]
|
